CLOSE X
GO

Kotak Healthcare Fund-Reg(G)

very highequitypharma & health care
13.15 -0.21(-1.56%) NAV as on 30 Mar 2026
-4.27 % 1 M
3.08 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.34

As on 28 Feb, 2026
age-icon Age :

2 yrs 3 m

Since 11 12 ,2023
exit_load Exit Load :

0.5%

aum AUM :

485.24 Crs

lock_in Lock-in :

0.50% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.12

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NIFTY HEALTHCARE INDEX - TRI

Fund_manager Fund Manager :

Shibani Kurian,Abhishek Bisen,Dhananjay Tikariha

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 1.26 %
Equity 98.74 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.53 %
Max Healthcare Institute Ltd.7.31 %
JB Chemicals & Pharmaceuticals...6.81 %
Divi's Laboratories Ltd.5.94 %
Fortis Healthcare Ltd.5.05 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.33
Hospital & Healthcare Services24.30
Miscellaneous1.66
Medical Equipment/Supplies/Accessories1.19
Business Support0.25
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-20252025-2026
NAV in Rs (as on 27-Mar-2026)11.3312.7513.36
Net Assets(Rs Crores) (as on 27-Mar-2026) 284.18 411.54 485.24
Scheme Returns(%)(Absolute)13.3211.675.97
B'mark Returns(%)(Absolute)NANANA
Category Rank77/9027/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Kotak Healthcare Fund-Reg(G)Very HighEquity13.15-0.21(-1.56%)NAV As on 30 Mar, 202611-Dec-2023Inception Date485.24AUM In Cr.3.08%1YNA%3YNA%5Y12.63%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity36.62-0.59(-1.59%)NAV As on 30 Mar, 202613-Jul-2018Inception Date6,801.16AUM In Cr.1.16%1Y25.44%3Y16.27%5Y18.32%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity415.51-5.79(-1.37%)NAV As on 30 Mar, 202614-Jul-1999Inception Date4,076.67AUM In Cr.0.94%1Y24.33%3Y16.41%5Y15.67%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity37.82-0.50(-1.32%)NAV As on 30 Mar, 202602-Jul-2018Inception Date2,843.74AUM In Cr.3.57%1Y23.63%3Y15.12%5Y18.73%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.19-0.36(-1.18%)NAV As on 30 Mar, 202610-Jul-2019Inception Date854.04AUM In Cr.2.69%1Y22.79%3Y13.43%5Y17.85%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors